CTSO
Cytosorbents (CTSO)
$61
About Cytosorbents (CTSO)
CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin in August 1997 and is headquartered in Princeton, NJ.
Details
Daily high
$0.63
Daily low
$0.60
Price at open
$0.63
52 Week High
$1.39
52 Week Low
$0.50
Market cap
38.2M
Dividend yield
0.00%
Volume
40,750
Avg. volume
53,037
P/E ratio
-4.57
Cytosorbents News
Details
Daily high
$0.63
Daily low
$0.60
Price at open
$0.63
52 Week High
$1.39
52 Week Low
$0.50
Market cap
38.2M
Dividend yield
0.00%
Volume
40,750
Avg. volume
53,037
P/E ratio
-4.57